217 related articles for article (PubMed ID: 21074689)
21. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
Zhang W; Hart J; McLeod HL; Wang HL
Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
[TBL] [Abstract][Full Text] [Related]
22. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
23. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
24. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
[TBL] [Abstract][Full Text] [Related]
25. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
Lam AK; Saleh S; Smith RA; Ho YH
Hum Pathol; 2008 Aug; 39(8):1229-33. PubMed ID: 18547619
[TBL] [Abstract][Full Text] [Related]
28. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
29. Telomerase expression in sebaceous lesions of the skin.
Olsen SH; Su LD; Thomas D; Fullen DR
J Cutan Pathol; 2007 May; 34(5):386-91. PubMed ID: 17448193
[TBL] [Abstract][Full Text] [Related]
30. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
[TBL] [Abstract][Full Text] [Related]
31. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
[TBL] [Abstract][Full Text] [Related]
32. Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma.
Yang CH; Hung WC; Wang SL; Kang WY; Chen WT; Huang YC; Su YC; Chai CY
APMIS; 2008 Apr; 116(4):309-16. PubMed ID: 18397466
[TBL] [Abstract][Full Text] [Related]
33. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
34. Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease.
Gonzalo V; Petit A; Castellví-Bel S; Pellisé M; Muñoz J; Piñol C; Rodríguez-Moranta F; Clofent J; Balaguer F; Giráldez MD; Ocaña T; Serradesanferm A; Grau J; Reñé JM; Panés J; Castells A
Gastroenterol Hepatol; 2010 Apr; 33(4):288-96. PubMed ID: 20334955
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of hTERT in potentially malignant colorectal laterally spreading tumors.
Li J; Cao X; Fang Y; Liao ZE; Liu YY; Huang BD; Han YJ
Mol Med Rep; 2013 May; 7(5):1409-12. PubMed ID: 23525166
[TBL] [Abstract][Full Text] [Related]
36. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.
Lledó SM; Garcia-Granero E; Dasí F; Ripoli R; García SA; Cervantes A; Aliño SF
Colorectal Dis; 2004 Jul; 6(4):236-42. PubMed ID: 15206965
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
38. [Expression of AIF and caspase-3 in colorectal carcinoma, adenoma, and normal mucosa and its correlation].
Guan JT; Wang L; Wang Y; Li Y; Wang R; Zhang WY; Zhan L; Zhou ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):391-4. PubMed ID: 19598027
[TBL] [Abstract][Full Text] [Related]
39. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.
Saleh S; Lam AK; Ho YH
Pathology; 2008 Jan; 40(1):25-30. PubMed ID: 18038311
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]